Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.680
+0.030 (1.82%)
At close: Aug 29, 2025, 4:00 PM
1.610
-0.070 (-4.17%)
After-hours: Aug 29, 2025, 5:37 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $5.78 million as of August 29, 2025. Its market cap has decreased by -16.18% in one year.
Market Cap
5.78M
Enterprise Value
2.81M
1-Year Change
-16.18%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $5.78M, a decrease of -90.13%. That is a compound annual growth rate of -45.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 5.78M | -60.29% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |